Behavioural Psychotherapy for Obsessive-Compulsive Disorder

References

• American Psychiatric Association. Diagnostic and Statistical Manual3rd edn, revised version. APA., Washington, DC 1987, DSM3-R
   Google Scholar
• Basoglu M., Lax T., Kasvikis Y., Marks I. Patterns and predictors of improvement in obsessive-compulsive disorder. Journal of Anxiety Disorders 1988; 2: 299–317
   Google Scholar
• Cooper J., Gelder M., Marks I. Results of behaviour therapy in 77 patients. British Medical Journal 1965; 1: 1222–1225
   PubMed Web of Science ®Google Scholar
• Cottraux J., Nury A. M., Mollard E., Bouvard M., Sluys M. Fluvoxamine and exposure in obsessive-compulsive disorder. A preliminary report on a post-test evaluation (European Association of Behaviour Therapy, Amsterdam). Fresh Perspectives on Anxiety Disorders. Annual Series of European Research in Behaviour Therapy, P. M. G. Emmelkamp. Swets, Amsterdam 1987; Vol. 4: 187–195, 1989
   Google Scholar
• Cottraux J., Messy P. Predictive factors in the treatment of obsessive-compulsive disorders with fluvoxamine or behavior Therapy, Behavior Therapy World Congress. Edinburgh 1988
   Google Scholar
• Cottraux J. Obsessions et compulsions. Nouvelles approches théoriques et thérapeutiques. Presses Universitaires de France, Paris 1989
   Google Scholar
• Cottraux J., Mollard E., Bouvard M., Marks I., Sluys M., Nury A. M., Douge R., Cialdella Ph. A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. International Journal of Clinical Psychopharmacology 1989, in press
   Google Scholar
• Emmelkamp P., Kraanen J. Therapist controlled exposure versus self-controlled exposure in vivo: a comparison with obsessive-compulsive patients. Behaviour Research and Therapy 1977; 15: 341–346
   Google Scholar
• Emmelkamp P., Van Der Helm M., Van Zanten B., Plochg I. Contribution of self-instructional training to the effectiveness of exposure in vivo: a comparison with obsessive-compulsive patients. Behaviour Research and Therapy 1980; 18: 61–66
   PubMed Web of Science ®Google Scholar
• Emmelkamp P. Phobic and Obsessive-compulsive Disorders. Theory, Research, and Practice. Plenum Press, New York 1982
   Google Scholar
• Emmelkamp P., Visser S., Hoekstra R. J. Cognitive therapy versus exposure in vivo in the treatment of obsessive-compulsive patients. Cognitive Therapy and Research 1988; 12: 103–114
   Web of Science ®Google Scholar
• Flament M., Rapoport J., Berg C., Murphy D., Lake R. Biochemical changes during Clomipramine treatment of childhood obsessive-compulsive disorder. Archives of General Psychiatry 1987; 44: 219–235
   PubMed Web of Science ®Google Scholar
• Foa E., Steketee G., Turner R. M., Fischer S. C. Effects of imaginal exposure to feared disasters in obsessive compulsive checkers. Behaviour Research and Therapy 1980; 18: 449–455
   PubMed Web of Science ®Google Scholar
• Foa E., Emmelkamp P. M. G. Failures in Behavior Therapy. John Wiley, New York 1983
   Google Scholar
• Foa E., Steketee G., Grayson J. B. Imaginal and in vivo exposure: a comparison with obsessive-compulsive checkers. Behavior Therapy 1985; 16: 292–302
   Web of Science ®Google Scholar
• Goodman W., Price H., Rasmussen S., Delgado P., Heninger G., Charney D. Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Archives of General Psychiatry 1989; 46: 36–44
   PubMed Web of Science ®Google Scholar
• Hackman A., McLean C. A comparison of flooding and thought-stopping treatment. Behaviour Research and Therapy 1975; 13: 263–269
   PubMedGoogle Scholar
• Hand I., Tichazky M. Behavioral group therapy for obsessions and compulsions: first results of a pilot study. Trends in Behavior Therapy. Academic Press, London 1979
   Google Scholar
• Hoogduin C., Duivenvoorden K. A decision model in the treatment of obsessive-compulsive neurosis. British Journal of Psychiatry 1988; 152: 516–521
   PubMed Web of Science ®Google Scholar
• Janet P. Les obsessions et la psychasthénie. Alcan, Paris 1903
   Google Scholar
• Jenike M. A. Neurobiology and neuropsychology of obsessive compulsive disorders. Obsessive-compulsive disorder, theory and management, M. A. Jenike, L. Baer, W. Minichiello. PSG., Littleton, MA 1986
   Google Scholar
• Kasvikis Y., Marks I. Clomipramine, self-exposure and therapist aided exposure in obsessive-compulsive ritualisers. II. Two year follow up. Journal of Anxiety Disorders 1988; 2: 291–298
   Google Scholar
• Lelliott P., Marks I. M. Management of obsessive-compulsive rituals associated with delusions, hallucinations & depression: a case study. Behavioural Psychotherapy 1987; 15: 77–87
   Google Scholar
• Marks I., Stern A., Mawson D., Cobb J., McDonald R. Clomipramine and exposure for obsessive-compulsive rituals. British Journal of Psychiatry 1980; 136: 1–25
   PubMed Web of Science ®Google Scholar
• Marks I. Fears, Phobias, and Rituals: panic, anxiety and their disorders. Oxford University Press, New York 1987
   Google Scholar
• Marks I., Lelliott P., Basoglu M., Noshirvani H., Monteiro H., Cohen D., Kasvikis Y. Clomipramine, self-exposure and therapist aided exposure in obsessive-compulsive ritualisers. British Journal of Psychiatry 1988; 152: 522–534
   PubMed Web of Science ®Google Scholar
• Mavissakalian M., Turner S., Michelson L., Jacob R. Tricylic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II. American Journal of Psychiatry 1985a; 142: 572–576
   PubMed Web of Science ®Google Scholar
• Mavissakalian M., Turner S., Michelson L. Obsessive-compulsive Disorder. Psychological and Pharmacological Treatment. Plenum Press, New York 1985b
   Google Scholar
• Mawson D., Marks I., Ramm L. Clomipramine and exposure for chronic obsessive-compulsive rituals III. Two year follow-up and further findings. British Journal of Psychiatry 1982; 140: 11–18
   PubMed Web of Science ®Google Scholar
• Meyer V. Modifications of expectations in cases with obsessional rituals. Behaviour Research and Therapy 1966; 4: 273–280
   PubMed Web of Science ®Google Scholar
• Meyer V., Levy A., Schnurer R. Behavioural treatment of obsessive-compulsive disorders. Obsessional States, H. R. Beech. Methuen, London 1974; 233–258
   Google Scholar
• Monteiro W., Lelliott P., Marks I., Noshirvani H. Anorgasmia from Clomipramine, in obsessive-compulsive disorder. British Journal of Psychiatry 1986; 151: 107–112
   Google Scholar
• O'Sullivan G., Marks I. Long term follow-up of agoraphobia, panic, and obsessive-compulsive disorders. Handbook of Anxiety, R. Noyes, et al. Elsevier, Amsterdam 1990; Vol. 4, [In press]
   Google Scholar
• O'Sullivan G., Noshirvani H., Marks I., Monteiro W., Lelliott P. Six year follow-up after exposure an Clomipramine for obsessive-compulsive disorder. 1990, In press
   Google Scholar
• Perse T., Greist J., Jefferson J., Rosenfeld R., Reuven D. Fluvoxamine treatment of obsessive-compulsive disorder. American Journal of Psychiatry 1987; 144: 1059–1061
   PubMedGoogle Scholar
• Price L., Goodman W., Charney D., Rasmussen S., Heninger G. Treatment of severe obsessive-compulsive disorder with fluvoxamine. American Journal of Psychiatry 1987; 144: 1059–1061
   PubMed Web of Science ®Google Scholar
• Rabavilas A., Boulougouris J., Perissaki C. Therapist qualities related to outcome with exposure in vivo in neurotic patients. Journal of Behavior Therapy an Experimental Psychiatry 1979; 10: 293–299
   Web of Science ®Google Scholar
• Rachman S., Hodgson R. Obsessions and Compulsions. Prentice Hall, Englewood Cliffs, NJ 1980
   Google Scholar
• Salkovskis P. Obsessional-compulsive problems. A cognitive behavioural analysis. Behaviour Research and Therapy 1985; 23: 571–583
   PubMed Web of Science ®Google Scholar
• Salkovskis P., Harrison J. Abnormal and normal obsessions—a replication. Behaviour Research and Therapy 1984; 22: 549–552
   PubMed Web of Science ®Google Scholar
• Salkovskis P., Warwick H. Cognitive therapy of obsessive-compulsive disorder. Cognitive Therapy. The Theory and Practice, C. Perris, I. Blackburn, H. Perris. Springer Verlag, Berlin 1988
   Google Scholar
• Solyom L., Sookman D. A comparison of clomipramine hydrochloride (Anafranil) and behaviour therapy in the treatment of obsessive-compulsive neurosis. Journal of Internal Medicine Research 1977, Supp. 5: 49–61
   PubMedGoogle Scholar
• Steketee G., Foa E., Grayson J. Recent advances in the treatment of obsessive-compulsive disorders. Archives of General Psychiatry 1982; 39: 1365–1370
   PubMed Web of Science ®Google Scholar
• Steketee G., Grayson J., Foa E. Obsessive-compulsive disorder: differences between washers and checkers. Behaviour Research and Therapy 1985; 23: 197–201
   PubMedGoogle Scholar
• Stern R., Marks I., Mawson D., Luscombe D. Clomipramine and exposure for compulsive rituals: II. Plasma levels, side effects and outcome. British Journal of Psychiatry 1980; 136: 161–166
   PubMedGoogle Scholar
• Stern R. Treatment of obsessive-compulsive disorders by thought stopping technique. Psychotherapy 1975; 25: 83–87
   Google Scholar
• Stern R. Obsessive thoughts: the problem of therapy. British Journal of Psychiatry 1978; 132: 200–205
   Google Scholar
• Thoren R., Asberg M., Cronholm B., Jonertedt L., Traskman L. Clomipramine treatment of obsessive-compulsive disorder: I—A controlled study. Archives of General Psychiatry 1980; 37: 1281–1285
   PubMed Web of Science ®Google Scholar
• Wolfe J. Psychotherapy by Reciprocal Inhibition. Stanford University Press. 1958
   Google Scholar
• Zohar J., Insel T. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment and pathophysiology. Biological Psychiatry 1987; 22: 667–687
   PubMed Web of Science ®Google Scholar
• Zohar J., Insel T., Berman K. F., Foa E., Berman K., Hill J., Weinberger D. Anxiety and cerebral blood flow during behavioral challenge. Dissociation of central from peripheral and subjective measures. American Journal of Psychiatry 1989; 46: 505–510
   Google Scholar